medac Pharma launch education platform, medac Academy

medac Pharma have launched a new digital education platform for UK healthcare professionals, medac Academy. Initially with content created for Urology nurses it features a range of 6 interactive modules which give a comprehensive evidence-based overview of Non-Muscle Invasive Bladder Cancer (NMIBC), from diagnosis and staging, to the more practical side of intravesical administration, finishing off with case studies which consolidate nurses learning from the modules using a ‘real life’ setting.

The NMIBC modules and case studies were written by Consultant Urologist Hugh Mostafid (Royal Surrey Hospital) and Clinical Nurse Specialist Kathryn Chatterton (Guys and St Thomas’) who have previously hosted practical workshops with medac Pharma for Urology nurses. Both Kathryn and Hugh are well known in the field of Urology and involved with EAUN and EAU respectively. They have drawn from their own experiences to create the module content.

When asked who will benefit from the medac Academy platform in Urology Kathryn Chatterton said, “I think they will benefit a whole range of nurses, from those newly qualified who want to learn more about bladder cancer, to nurses wanting to undertake intravesical therapy and experienced nurses who will be able to use this to recap and refresh on the literature available.”

The content has been accredited by the CPD Certification Service and will allow nurses to undertake the modules as part of their Continued Professional Development. This can be done at a time that suits each individual and the design of the modules allows nurses to pick up where they left off when returning to them after a break.

Paula Alchorne, President Elect of EAUN has reviewed the educational content and has praised them for consolidating clinical information and guidelines on NMIBC in one space as this is something that has not been easily accessible in the past;

“I have been a urology nurse for more than 25 years, I could only have hoped for a course like this when I first started treating patients with intravesical treatments. ​ I found it covered a wide breadth of urology knowledge and made me think about certain components. It covers a range of different topics including case studies which I thought was a great idea. I will definitely get the rest of my Bladder Cancer CNSs to do the online course.”

Group Product Manager for Oncology and Urology at medac Pharma, Alex Riley comments, “We know that Bladder Cancer nurses really appreciated the Workshops we held previously as a place to learn from their peers so ensured Urology content for our Education Platform was a priority. We are delighted the modules have been received so well and hope that they will be useful to urology nurses at all stages in their career.”

The company plan to continually release new educational content for UK healthcare professionals in different formats over a number of therapeutic areas including rheumatology and oncology.

UK Healthcare Professionals interested in signing up for the medac Academy Education Platform can do so by visiting www.medacacademy.co.uk.

About medac Academy
medac Academy provides Healthcare Professionals with free learning and events within their therapy area. The learning hub provides quality education that include clinical data, best practice approaches and the opportunity to attain required CPD points at each HCPs own pace.

www.medacacademy.co.uk

 

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.

About medac Pharma

medac Pharma is a privately owned, pharmaceutical company specialising in product development and the treatment of diseases within the key areas of oncology, autoimmune and urology.

medac GmbH was originally founded in Germany in 1970 and the UK operation was established in 1993. Since then we have become known for developing innovative products, especially in less common indications, which have resulted in a comprehensive portfolio of pharmaceutical products which help make a positive difference to the lives of your patients. We are committed to supplying therapeutic products and providing the diagnostic resources to identify diseases. We continue to invest in our manufacturing and logistic capabilities to ensure we meet the increasing demand of both healthcare professionals and patients’ needs.

Contact

Scion House Stirling University Innovation Park Stirling FK9 4NF

01786 458086

[email protected]

www.medacpharma.co.uk